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non-symptomatic groups and blood neutrophils tended to 
increase in the symptomatic welder group. The morning 
after, neutrophils and serum IL-8 had decreased in all three 
groups after welding exposure. Remarkably, the symp-
tomatic welder group had a tenfold higher level of EBC 
LT-B4 compared to the two groups without symptoms.
Conclusion Despite no clinical adverse effects at welding, 
changes in inflammatory markers may indicate subclinical 
effects even at exposure below the present Swedish thresh-
old limit (8 h TWA respirable dust).
Keywords Occupational exposure · Exhaled breath 
condensate · Nasal lavage · Leukotriene B4 · Interleukin 6 
and 8
Introduction
Welders are a large group of workers exposed to gases and 
particles which can cause adverse effects in airways such 
as bronchitis, asthma and metal fume fever (Antonini et al. 
2003). Furthermore, the immune system may be affected, 
with impaired resolution of local inflammation and reduced 
capacity to eliminate infectious agents (Zeidler-Erdely et al. 
2012). Welding in mild steel accounts for the majority of 
all welding (Taube 2013). Although such welding has often 
been looked upon as less harmful than other forms of weld-
ing, an increasing number of studies show adverse effects 
also at mild steel welding even at moderate exposure levels 
(Lillienberg et al. 2008; Jönsson et al. 2011, 2015; Hedmer 
et al. 2014).
Exposure at mild steel welding is complex and var-
ies depending on welding method, electrode used and the 
material being welded. The particles generated are often in 
the nano-size range, initially between 10 and 100 nm while 
Abstract 
Purpose Welders are exposed to airborne particles from 
the welding environment and often develop symptoms 
work-related from the airways. A large fraction of the par-
ticles from welding are in the nano-size range. In this study 
we investigate if the welders’ airways are affected by expo-
sure to particles derived from gas metal arc welding in mild 
steel in levels corresponding to a normal welding day.
Method In an exposure chamber, 11 welders with and 10 
welders without work-related symptoms from the lower air-
ways and 11 non-welders without symptoms, were exposed 
to welding fumes (1 mg/m3) and to filtered air, respectively, 
in a double-blind manner. Symptoms from eyes and upper 
and lower airways and lung function were registered. Blood 
and nasal lavage (NL) were sampled before, immediately 
after and the morning after exposure for analysis of mark-
ers of oxidative stress. Exhaled breath condensate (EBC) 
for analysis of leukotriene B4 (LT-B4) was sampled before, 
during and immediately after exposure.
Results No adverse effects of welding exposure were 
found regarding symptoms and lung function. How-
ever, EBC LT-B4 decreased significantly in all partici-
pants after welding exposure compared to filtered air. 
NL IL-6 increased immediately after exposure in the two 
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later aggregating to larger complexes (Zimmer and Biswas 
2001).
There is growing evidence that particles in the nano 
range (i.e. <100 nm) may be more toxic than bigger ones, 
at equal mass concentration, because of their high surface-
to-mass ratio and smaller radius which make them more 
chemically reactive and also more potent inducers of oxida-
tive stress and subsequent inflammation (Ferin et al. 1992; 
Oberdörster et al. 2005; Tran et al. 2000; Donaldson et al. 
2002; Renwick et al. 2004).
However, welders may also be exposed to larger par-
ticles, e.g. at grinding the welded material (Zimmer and 
Maynard 2002). In an earlier study, we found that although 
the symptoms in welders increased significantly during 
working days the association with the welding exposure 
was not clear (Jönsson et  al. 2015). As the welders also 
ground the welded material, it was difficult to conclude 
to what degree the symptoms were elicited by the weld-
ing fumes. Such knowledge is important for the preventive 
work.
The objective of this study was to clarify if exposure to 
fumes from gas metal arc welding in mild steel in a level 
found in the industry in Sweden today affects the airways 




A panel of welders was selected from six welding com-
panies in southern Sweden. The panel consisted of a 
group of welders with work-related symptoms from the 
low airways in the last month (WS) and another group of 
welders without such symptoms (WNS). A third group 
of non-welding subjects without low airways symptoms 
(NWNS) was also included. Nobody was current smok-
ers (never smokers or ex-smokers for at least 5 years) and 
they had no regular medication.
All the welders in the companies were asked to fill 
in a self-administered screening questionnaire (Drex-
ler et  al. 1999) containing questions regarding employ-
ment, exposure, smoking habits, allergies and work-
related symptoms from eyes and airways. Work-related 
symptoms were defined as symptoms where recovery 
occurred during weekends and holidays (Ferris 1978). 
Thirty-four (25%) out of 134 welders had experienced 
work-related symptoms from the lower airways (wheez-
ing, dyspnoea or cough) the last month. Of this group, 21 
subjects were eligible for the WS group. They were con-
secutively asked to participate. Participants to the WNS 
group were matched to the symptomatic ones as good as 
possible with regard to company, total welding time, age, 
earlier smoking and atopy. The participants to the NWNS 
group were chosen from workers in a storeroom in one of 
the welding factories or from another mechanical indus-
try without welding exposure. These subjects were not 
exposed to respiratory irritants. As the number of female 
welders was small only male subjects were selected.
The age, the total time as a welder and results from the 
basal medical examination (as described below) are given 
in Tables 1 and 2. Nobody has diagnosed airway diseases. 
Subjects with acute symptoms from the eyes and airways 
such as common cold were not allowed to participate. 
The study was carried out outside the pollen season.
The study was approved by the regional ethical com-
mittee at Lund University (H4 160/2007) and performed 
according to the Declaration of Helsinki. An informed 
Table 1  Age, lifetime welding, 
smoking habits, skin-prick 
test (SPT) positivity and lung 
function, forced vital capacity 
(FVC) and forced expiratory 
volume in the first second 
 (FEV1), in percent of expected 
and work-related symptoms 
from eyes and nose at least 
once a week the last month in 
welders with symptoms from 
the lower airways (WS), welders 
with no symptoms (WNS) 
and in non-welders with no 
symptoms (NWNS) at the basal 
examination before the study







Age, years (median; min, max) 42 (29–66) 51 (34–66) 47.5 (29–66)
Welding time, years (median; min, max) 14 (2–39) 31 (2–43) –
Smoking habits (N; %)
 Present 0 0 0
 Never 5 (45.5) 4 (40) 8 (72.7)
SPT positivity (N; %) 3 (27.3) 1 (10.0) 1 (9.1)
Lungfunction (median; min, max)
 FVC % 99.2 (72–114) 94.0 (80–117) 99.8 (89–121)
 FEV1 % 101.0 (66–132) 93.4 (75–128) 104.1 (91–129)
Symptoms (N)
 Eyes 1 1 1
 Nose 6a 1 2
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written consent was obtained from all participants prior 
to exposure.
Study design
The participants were randomly exposed twice at dif-
ferent occasions either to welding fume or to filtered air 
(FA) respectively, in a double-blind manner in an expo-
sure chamber. The average time between the two expo-
sures were two weeks (min–max: 1–8 weeks). Each expo-
sure time was 5.5 h with a lunch break for 1 h after 2.5 h 
of exposure. Exposure occurred on Mondays, ensuring 
that the welders had not been exposed to welding fume 
for at least 48  h prior to the exposure. The participants 
went through medical examinations including lung aus-
cultation, spirometry and acoustic rhinometry before and 
immediately (30–60 min) after exposure. Symptoms and 
peak expiratory flow (PEF) were registered before, during 
(10 min, 1 h 10 min, 2 h 45 min, 4 h 10 min, 5 h 10 min 
after start) and immediately after the exposure. To study 
markers of oxidative stress nasal lavage (NL), urine- and 
blood samples were obtained before and immediately 
after the exposure and, if practically possible, also the 
morning after (N = 30 persons after welding exposure, 
N = 28 persons after FA exposure). Furthermore, exhaled 
breath condensate (EBC) was sampled before the expo-
sure, at the beginning of the lunch break, and immedi-
ately after the exposure. The subjects were in rest during 
the exposures.
Exposure chamber and exposure
The chamber conditions and generation system of welding 
fumes and FA are described in detail in Isaxon et al. (2013). 
In short, the chamber was a stainless steel room (21.6 m3) 
having a capacity of comfortably keeping three partici-
pants sitting at the same time. It was supplied with clean air 
through a separate conditioning system by which air flow, 
temperature and relative humidity could be controlled.
Particles for exposure were derived from metal active 
gas (MAG) welding in mild steel using a shielding gas mix-
ture Ar/CO2 (82/18%) and a 1  mm in diameter electrode 
with a feeding rate of 3 cm/s. The welding was carried out 
in a box located in an adjacent room out of sight for the 
test subjects and the medical staff. Welding was performed 
for 3 min in a 20-min cycle throughout the exposure event. 
This non-uniform exposure resembles real work situations. 
The welding fume was supplied to the clean air flow just 
prior to entering the chamber. The time from generation of 
welding fume to the chamber was 2  s. Continuous moni-
toring and averaging of the mass concentration with a cus-
tom-built computer program made it possible to increase 
or decrease the welding time of each pulse, as well as the 
pulse frequency, toward the desired mean concentration. 
During the exposures,  PM2.5 particle mass concentration in 
the chamber was monitored with a Tapered Element Oscil-
lating Microbalance (TEOM) with a cyclone as a precol-
lector for particles larger than 2.5 µm. The particle number 
concentration and mobility size distribution (10–650  nm) 
were measured using a Scanning Mobility Particle Sizer 
Table 2  The welders with symptoms from the lower airways during the last month, skin-prick test positivity for a standard panel of aero aller-
gens, metacholine test (MCH) positivity and lung function (FVC and  FEV1 as % of predicted) at the basal medical examination before the study
nc Not calculable
a MCH  PD15 is defined as the provocative dose that cause a 15% decrease in the  FEV1 from the baseline. A positive test is defined as 
 PD15 < 167 µg
b Test inhibited by cough
Nasal Lower airways Skin-prick test MCH  PD15a FVC% FEV1%
1 No Dyspnoea Negative 192 114 114
2 Yes Dyspnoea, cough Positive (birch, timothy, mug wort) nc 93 101
3 No Cough Negative nc 101 100
4 Yes Cough Negative nc 72 74
5 Yes Wheezing breath Negative 49 79 71
6 Yes Dyspnoea, cough, wheezing Negative nc 105 108
7 No Cough Positive (house mites) nc 99 101
8 Yes Dyspnoea, wheezing Positive (timothy, cat, dog) 3 82 66
9 Yes Cough Negative nc 85 90
10 No Dyspnoea, cough, wheezing Negative nc 114 132
11 No Dyspnoea, cough Negative –b 108 127
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(SMPS) system. The chemical composition of the welding 
aerosol was characterized by PIXE and X-ray energy dis-
persive spectroscopy (XEDS).
Generation of welding fume followed the same time 
schedule, whether the participants were exposed to welding 
fume or to FA only. In the case of FA exposure, the gener-
ated welding fume was bypassed the exposure chamber.
The procedure proved to deliver reproducible results 
throughout the number of exposure events, with a mean 
particle number concentration of 64,300/cm3 and a stand-
ard deviation between the mean values of different expo-
sure events (SDoM), of 15,000,  PM2.5 mass concentration 
1000 µg/m3 (SDoM: 70),  CO2 670 ppm (SDoM: 134), RH 
26.9% (SDoM: 1.7) and temperature 23.3 °C (SDoM: 1.0). 
The geometric count median diameter of particles was 
160 nm with a variation between the different events up to 
±10%. The count mean diameter of the number size distri-
butions is 190 nm, with the 5th and 95th percentiles of 47 
and 570 nm, respectively.
The median mass concentration during all exposure 
events was 946 µg/m3, with the 1st and 3rd quartiles 633 
and 1307  µg/m3, respectively. The elemental composition 
in mass % was iron 70%, and manganese 20%. The remain-
ing 10% contained silica (4.5%) and metals such as copper 
and zinc (Isaxon et al. 2013).
Basal medical examination
Before the exposure the participants went through a gen-
eral medical examination including standardized questions 
about past and present respiratory and cardio-vascular dis-
eases and allergies (Tables 1, 2). They were also asked for 
specific symptoms from eyes and airways including dry and 
productive cough. Chronic bronchitis was defined accord-
ing to the Medical Research Council Committee (1965). 
A standard skin-prick test and a spirometry were also per-
formed (see below). Participants with symptoms from the 
lower airways went through a methacholine test (MCH) for 
the assessment of the nonspecific bronchial hyper-reactivity 
(Table 2). This test could not be carried out in one partici-
pant because of cough. Nobody turned out to have any cur-
rent disease including chronic bronchitis and allergic symp-
toms. Because of asthma-like symptoms one subject was 
prescribed salbutamol when necessary.
Medical methods
Symptoms were recorded using a visual analogue scale 
(Molen 1995; Dorman et  al. 2007). Symptoms from the 
eyes (scratching, burning or itching), the nose (running, 
itching/sneezing, blocked and bleeding), the pharynx (sen-
sation of dryness, irritation and/or itching, hoarseness/
rough voice and mucus), and from lower airways (attacks 
of dyspnoea, chest tightness, wheezing breath, and dry or 
productive cough) were registered.
Skin-prick test (SPT) was carried out on the volar part of 
the forearm using 12 aeroallergens [birch, grasses (Phleum 
prat., Dactylis glom., Arrhenatherum elat.), mugwort, cat, 
dog, horse, house dust mite (Dermatophagoides pteronys-
sinus), moulds (Cladosporium herb., Alternaria alt., Asper-
gillus fum.)], and read after 15  min (ALK Abello A/S, 
Copenhagen, Denmark). Reaction sizes were recorded in 
relation to histamine (10  mg/ml), according to Aas and 
Belin (1973).
PEF was measured with a Mini Wright Flow Meter 
(measuring range of 60–800 L/min), three recordings each 
time. The best one will be taken for the statistical analysis 
(Brusasco et al. 2005; Miller et al. 2005).
Spirometry was performed with SPIRARE 3 (DIAG-
NOSTICA, Oslo, Norway) according to the European Res-
piratory Society, ERS (Miller et  al. 2005; Quanjer et  al. 
1993). Vital capacity (VC) and Forced expiratory flow in 
the first second  (FEV1) were obtained and compared to a 
standard material (Berglund et al. 1963).
MCH was performed according to Larsson et al. (2007). 
In short, a jet nebulizer (Spira Elektro 2; Respiratory Care 
Center, Hämeenlinna; Finland) was used. Methacholine 
chloride in saline was administered in six successive cumu-
lative doses (2, 10, 40, 160, 460 and 1360 μg).  FEV1 was 
measured at 1 and 3  min after each inhalation step. The 
person was considered hyper-reactive when  FEV1 fell more 
than 15% compared to the baseline at a total dose of 167 μg 
or less (Larsson et al. 2007).
Acoustic rhinometry was performed using a RhinoScan 
v. 2.5 (Interacoustics A/S, Assens, Denmark) according to 
the producers advises with the participant sitting with fixed 
neck. The minimum cross-sectional area between 0 and 
22 mm from nares and between 22 and 54 mm (MCA 1 and 
MCA 2, respectively) and the nasal volume between these 
distances (Volume 1 and Volume 2, respectively) were 
recorded (Hilberg 2002). The mean value of three consecu-
tive measurements for each nostril was registered and the 
result is given as the sum.
EBC was sampled using an RTube (Respiratory 
Research, Charlottesville, VA, USA). The subject took 15 
deep breathes into the RTube which was cooled to –25 °C. 
The condensate was then allocated to tubes in amounts of 
50 µl each and frozen at −80 °C for later analysis.
NL was carried out as earlier described (Xu et  al. 
2013) using 18  ml 37 °C 0.9% NaCl solution. After 
cell separation the pellet was suspended in a volume of 
500  μl by a 0.9% NaCl solution, and 200  μl each were 
transformed to glass slides using a cytospin centrifuge 
(600 rpm for 5 min, Cytospin 2, Shandon Inc. Pittsburgh, 
PA, USA).The slides were air dried. The supernatant was 
pipetted to two Cryovial tubes prepared with inhibitor 
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according to Cho et  al. (2003) and frozen at −80 °C. It 
was not possible to get NL from one of the participants.
Laboratory analyses
The NL cells were stained by the May-Grünewald-
Giemsa method. A total of 100 granulocytes were 
counted and the share of eosinophils was recorded. The 
reading was blindly performed.
Blood samples were analyzed for hemoglobin and 
a differential count of white blood cells was performed 
using Sysmex XE-5000 and Sysmex XE-1800i. Fibrino-
gen was analyzed in plasma by using Sysmex CA-7000 
according to the instruction of the manufacturer. C-reac-
tive protein (CRP) was analyzed in plasma by using the 
instrument Cobas c501. The analyses were performed at 
the Division of Clinical Chemistry at Lund University 
Hospital.
The cytokines ICAM, IL-6, IL-8 and TNF-α in nasal 
lavage, and IL-6 and IL-8 in serum were analysed using 
a multiplexed immunoassay Luminex-platform (Bio-Plex 
200, Bio-Rad Life Science, Hercules, CA). Commercially 
available kits were purchased from Bio-Rad (Bio-Rad 
Life Science, Hercules, CA). The analysis was performed 
according to the instructions of the manufacturer. Bovine 
serum albumin (BSA) was added to nasal lavage samples 
and standards to a final concentration of 0.5% BSA. All 
samples were analysed in duplicates. Samples with values 
below the limit of detection (LOD) were awarded in the 
statistical analysis a value equal to half LODs. The LODs 
were in nasal lavage 0.43 for IL-6, 0.42 for IL-8, 1.5 for 
TNF-α and 7.8 for ICAM; in serum 0.44 for IL-6 and 0.35 
for IL-8 (pg/ml).
The concentration of 8-oxo-21-deoxyguanosine (8-oxo-
dG) in urine was measured using liquid chromatography 
tandem mass spectrometry with prior purification using 
solid-phase extraction according to Teichert et  al. (2009) 
with some modifications (Engström et  al. 2010). Detec-
tion limit was 10 pg/ml and the coefficient of variation in a 
quality control sample at 9 ng/ml was 10%.
Leukotriene B4 in exhaled air condensate was analysed 
using commercial LT-B4 EIA kit from EnzoLife Sciences 
(Enzo Life Science AG, Lausen, Switzerland) according to 
the protocols supplied by the manufacturer. The analyses 
were performed at the Division of Occupational and Envi-
ronmental medicine, Lund University.
Club cell protein (CC16) in serum was analysed at the 
Department of Occupational and Environmental medicine 
in Gothenburg, using commercial ELISA kits from BioV-
endor (BioVendor Laboratory Medicine, Inc., Brno, Czech 
Republic), according to the protocols supplied by the 
manufacturer.
Statistics
Differences between welding and FA exposure for single 
time points were assessed by odds ratios (ORs) with 95% 
confidence intervals (CIs), estimated by logistic regres-
sion. Changes over time were investigated using repeated 
measures mixed models (continuous outcomes) or gen-
eral linear models with repeated measures (categorical 
outcomes).
Possible interactions between exposure (welding fume/
filtered air) and subgroups (WS, WNS and NWNS) were 
assessed by adding an interaction term between the expo-
sure and the subgroup.
When the outcome variables are ln-transformed, it is 
not entirely clear how the results from the statistical anal-
yses should be interpreted. Therefore, the point estimates 
and associated confidence limits have been transformed 
with the formula 100 ×  (eB−1). The results can then be 
interpreted as the percentage increase/decrease in mean 
in the evaluated group (Vittinghoff et al. 2005).
For continuous outcomes where it was necessary to use 
non-parametric tests, differences between welding and fil-
tered air exposure were analysed with Friedman’s two-way 
analysis of variance. For such analyses, it was not possible 
to adjust for the order of exposure or examine interaction 
effects. For those variables that cannot be analysed with 
general linear models we present only group medians. All 
analyses were performed in SPSS 18.0.
Results
Symptoms
Symptoms were frequently reported both before weld-
ing and FA exposure. A significant decrease in nasal 
Table 3  Number of persons with nasal symptoms at different time 
points at welding and filtered air (FA) exposure and odds ratios (OR) 









Before exposure 18 (56) 15 (47) 1.46 (0.70, 3.05) 0.31
After start
 10 min 13 (41) 13 (41) 1.00 (0.59, 1.70) 1.00
 1h 10 min 12 (38) 11 (34) 1.16 (0.62, 2.17) 0.65
 2h 45 min 10 (31) 13 (41) 0.66 (0.42, 1.04) 0.07
 4h 10 min 8 (25) 14 (44) 0.43 (0.23, 0.80) 0.01
 5h 10 min 10 (31) 15 (47) 0.51 (0.30, 0.89) 0.02
 5h 30 min 9 (28) 14 (44) 0.50 (0.25, 0.99) 0.05
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symptoms was registered at welding exposure at 4  h 
10  min and onward (Table  3). No other consistent 
changes during the exposures were found regarding num-
ber of persons with symptoms or in intensity of symp-
toms as studied from the VAS scales (data not shown). 
No significant interactions between exposure and sub-
groups were noticed.
Medical examinations
No significant changes from before to immediately after 
exposure were found regarding lung auscultation in the 
whole group and in the subgroups at welding or filtered air 
exposure (data not shown).
In rhinometry no significant changes were noticed 
in the total group at welding compared to FA exposure 
(Table  4). Significant interactions between exposure and 
subgroups were found for all studied parameters (MCA 2 
p = 0.04; Volume 1 p = 0.02 and Volume 2 p = 0.03) except 
for MCA 1 which was close to significant (p = 0.06; results 
for Volume 1 and 2 are shown in Table 4). The WS group 
increased most in all measures indicating a nasal opening 
during welding exposure whereas the NWNS group tended 
to decrease.
No effects of welding exposure were registered by 
spirometry or by PEF in the whole group and in the sub-
groups (data not shown).
Blood
In the total group, neutrophils did not change immediately 
after welding exposure compared to FA (Table 5). A ten-
dency to interact between the exposure and the levels of 
neutrophils in the subgroups was noticed with an increase 
predominantly in the WS group immediately after welding 
exposure (Table 5). On the contrary, the day after exposure 
a significant decrease was noticed in the whole group, most 
clearly in the two non-symptomatic groups (Fig.  1). No 
Table 4  Rhinometry before and after, and the changes (Δ) (mean, 
standard deviation) from before to immediately after exposure to 
welding fumes and filtered air (FA), respectively, in the total group 
and in the subgroups of welders with symptoms from the lower air-
ways (WS), welders with no symptoms (WNS) and in healthy non-
welders (NWNS)
A positive result means an increase in the parameter studied from before to after exposure
p-values for interaction between the exposure and the subgroups: p = 0.02 (Volume 1), p = 0.03 (Volume 2)
Volume 1  (cm3) Volume 2  (cm3)
Total group WS WNS NWNS Total group WS WNS NWNS
Welding
 Before 4.37 (0.74) 4.50 (0.53) 4.44 (0.97) 4.18 (0.72) 8.27 (3.23) 7.02 (1.78) 9.40 (4.80) 8.48 (2.32)
 After 4.49 (0.77) 4.78 (0.60) 4.49 (0.90) 4.20 (0.74) 9.81 (4.17) 9.56 (2.89) 10.95 (4.49) 9.03 (5.03)
 Δ before to after 0.12 (0.23) 0.28 (0.19) 0.05 (0.16) 0.01 (0.24) 1.55 (2.78) 2.54 (2.20) 1.55 (2.52) 0.55 (3.36)
FA
 Before 4.38 (0.75) 4.49 (0.67) 4.49 (0.87) 4.16 (0.73) 8.57 (3.59) 8.01 (2.50) 9.79 (3.33) 8.01 (4.64)
 After 4.51 (0.69) 4.60 (0.57) 4.53 (0.91) 4.40 (0.62) 9.00 (3.42) 7.80 (2.40) 10.67 (3.80) 8.68 (3.60)
 Δ before to after 0.13 (0.32) 0.11 (0.26) 0.04 (0.34) 0.24 (0.35) 0.43 (1.96) -0.21 (2.45) 0.89 (1.84) 0.67 (1.47)
Table 5  The levels in blood 
neutrophils before, immediately 
after and the morning after the 
exposure to welding and filtered 
air (FA), and the changes (Δ) 
(mean, standard deviation), 
respectively, in the total group 
and in the subgroups of welders 
with symptoms from the lower 
airways (WS), welders with 
no symptoms (WNS) and in 
healthy non-welders (NWNS)
p values for interaction between the exposure and the subgroups: p = 0.08 (before to after) and p = 0.09 
(before to the morning after)
Blood neutrophils Total group WS WNS NWNS
Welding Before 3.59 (1.11) 3.38 (0.50) 4.11 (1.76) 3.32 (0.65)
After 3.71 (0.81) 3.96 (0.89) 3.53 (0.92) 3.62 (0.62)
Morning after 3.22 (0.79) 3.20 (0.62) 3.41 (1.14) 3.08 (0.60)
ΔBefore to after 0.12 (0.95) 0.57 (0.88) −0.58 (0.98) 0.30 (0.63)
ΔBefore to morning after −0.43 (0.69) −0.22 (0.61) −0.89 (0.77) −0.24 (0.55)
FA Before 3.47 (1.36) 3.51 (0.63) 3.74 (1.96) 3.18 (1.31)
After 3.63 (1.50) 3.67 (0.70) 3.75 (1.77) 3.47 (1.91)
Morning after 3.48 (1.47) 3.08 (0.44) 3.65 (1.67) 3.67 (1.88)
ΔBefore to after 0.16 (0.77) 0.16 (0.72) 0.01 (0.56) 0.29 (0.99)
ΔBefore to morning after −0.04 (0.75) −0.36 (0.42) −0.43 (0.59) 0.49 (0.79)
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significant changes were associated with welding exposure 
compared to FA regarding lymphocytes, eosinophils and 
monocytes in the total group. Neither were effects of bron-
chial reactivity, atopy or life time welding noticed (data not 
shown).
Serum IL-8 decreased significantly in the morning 
after welding in the total group compared to FA exposure 
(Table 6). The decrease was mainly seen in the WS group 
(Fig.  2). There were no significant changes in fibrinogen, 
C-reactive protein, CC16 and IL-6 in the total group and in 
the subgroups. Neither were effects of bronchial reactivity, 
atopy or life time welding noticed (data not shown).
NL, EBC and urine
There was a significant increase in NL IL-6 immediately 
after welding compared to FA exposure in the total group 
(p = 0.02), but this increase was only seen in the asymp-
tomatic subgroups (Table  7; Fig.  3). No effects of weld-
ing were seen in the morning after. No effects of welding 
fumes were seen in IL-8 or in the numbers of eosinophilic 
cells, ICAM and TNF-α (data not shown).
Regarding EBC, the WS group had about 10 time’s 
higher LT-B4 value than the other two asymptomatic sub-
groups before exposure to welding fume as well as to fil-
tered air (Table  8). LT-B4 decreased during welding, but 
not at FA exposure in the whole group. Immediately after 
exposure the difference between welding and FA was sig-
nificant (p = 0.02). The decrease was noticed in all the 
subgroups.
We saw no effects of welding exposure on 8-oxo-dG in 
urine, whether it was creatinine- or density adjusted, nei-
ther in the whole group nor in the subgroups after and the 
morning after the exposure (data not shown).
Discussion
In this study of acute effects of mild steel welding fume 
exposure in welders with and without work-related symp-
toms from lower airways and in non-welders, we found no 
Fig. 1  The changes in neutrophils in blood  (109/l) from before to the morning after exposure to welding fume and filtered air respectively in 
subjects with and without low airway symptoms. A positive value means an increase from before to after exposure
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Table 6  The levels in IL-8 in serum (pg/ml) before, immediately 
after and the morning after the exposure to welding and filtered air 
(FA), and the changes (Δ) (mean, standard deviation), respectively, in 
the total group and in the subgroups of welders with symptoms from 
the lower airways (WS), welders with no symptoms (WNS) and in 
healthy non-welders (NWNS)
A positive result means an increase in the parameter studied from before to after the exposure
p values for interaction between welding and FA: p = ns (before to after) and p = 0.01 (before to the morning after)
ns not significant
IL-8 in serum Total group WS WNS NWNS
Welding Before 6.34 (0.0, 21.9) 7.09 (0.0, 20.3) 6.50 (3.0, 12.6) 5.28 (2.7, 21.9)
After 6.35 (3.4, 24.1) 6.39 (4.6, 24.1) 7.13 (3.4, 13.8) 5.36 (4.2, 18.4)
Morning after 5.23 (0.0, 26.1) 5.60 (0.0, 26.1) 5.42 (2.8, 11.1) 4.82 (0.0, 21.1)
ΔBefore to after 0.23 (−4.57, 4.85) 0.00 (−2.28, 4.44) 0.57 (−4.57, 4.85) 0.33 (−3.52, 1.76)
ΔBefore to morning after −1.06 (−7.33, 5.87) −1.59 (−7.33, 5.87) −1.00 (−3.09, 3.08) −0.81 (−3.86, 2.16)
FA Before 6.31 (0.0, 21.6) 5.50 (0.0, 21.6) 6.48 (3.3, 11.9) 6.31 (2.5, 19.8)
After 6.68 (0.0, 26.1) 6.44 (0.0, 16.9) 6.32 (3.7, 13.1) 8.18 (3.3, 26.1)
Morning after 6.82 (0.0, 16.6) 6.98 (4.4, 10.5) 7.22 (5.6, 16.6) 6.57 (0.0, 14.3)
ΔBefore to after 0.31 (−5.95, 6.35) 0.00 (−5.95, 3.23) 0.13 (−1.88, 1.98) 1.69 (−3.66, 6.35)
ΔBefore to morning after 0.20 (−6.87, 9.57) 0.00 (−6.79, 9.57) 1.54 (−1.07, 4.68) −0.53 (−6.87, 2.30)
Fig. 2  The changes in serum IL-8 (pg/ml) from before to the morning after exposure to welding fume and filtered air respectively in subjects 
with and without low airway symptoms. A positive value means an increase from before to after exposure
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consistent increase in symptoms. Contrary, welders, espe-
cially those in the WS group, had a tendency to improve 
in nasal symptoms and in rhinometry during the exposure. 
Despite the lack of clinical effects, changes in some bio-
markers at welding exposure compared to FA (blood neu-
trophils and IL-8 in serum, IL-6 in nasal lavage and LT-B4 
Table 7  The levels in IL-6 in nasal lavage (pg/ml) before, imme-
diately after and the morning after the exposure to welding and fil-
tered air (FA), and the changes (Δ) (mean, standard deviation), 
respectively, in the total group and in the subgroups of welders with 
symptoms from the lower airways (WS), welders with no symptoms 
(WNS) and in healthy non-welders (NWNS)
A positive result means an increase in the parameter studied from before to after the exposure
p values for interaction between welding and FA: p = 0.02 (before to after) and p = ns (before to the morning after)
ns not significant
IL-6 in nasal lavage Total group WS WNS NWNS
Welding Before 0.80 (0.0, 45.5) 1.04 (0.0, 4.6) 0.32 (0.0, 45.5) 1.01 (0.0, 8.6)
After 1.22 (0.0, 47,0) 0.67 (0.0, 6.0) 1.46 (0.0, 47.0) 1.73 (0.0, 10.4)
Morning after 0.92 (0.0, 31.4) 0.84 (0.0, 8.3) 1.20 (0.0, 31.4) 0.88 (0.0, 4.7)
ΔBefore to after 0.28 (−1.72, 8.05) 0.00 (−1.34, 1.43) 0.90 (−0.42, 4.20) 0.54 (−1.72, 8.05)
ΔBefore to morning after 0.00 (−14.10, 8.14) 0.00 (−0.84, 3.66) 0.31 (−14.10, 8.14) −0.20 (−4.80, 0.80)
FA Before 1.17 (0.0, 152.2) 1.33 (0.0, 4.8) 1.05 (0.0, 25.7) 1.54 (0.0, 152.2)
After 1.28 (0.0, 60.3) 0.98 (0.0, 3.0) 1.33 (0.0, 11.7) 4.09 (0.0, 60.3)
Morning after 1.53 (0.0, 88.9) 1.17 (0.0, 3.2) 0.88 (0.0, 85.1) 4.04 (0.0, 88.9)
ΔBefore to after 0.00 (−91.88, 3.61) 0.00 (−3.50, 0.36) 0.11 (−14.02, 1.17) 0.00 (−91.88, 3.61)
ΔBefore to morning after 0.06 (−83.34, 59.37) 0.13 (−2.88, 1.85) 0.27 (−0.55, 59.37) 0.00 (−83.34, 3.83)
Fig. 3  The changes in nasal lavage IL-6 (pg/ml) from before to immediately after exposure to welding fume and filtered air respectively in sub-
jects with and without low airway symptoms. A positive value means an increase from before to after exposure
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in exhaled breath condensate) indicate subclinical effects 
of the exposure. Interestingly, the WS group had a 10-fold 
higher LT-B4 level in exhaled air before the exposure com-
pared to the two other groups.
As the exposure may be characterized as moderate com-
pared to real-life exposure at welding workshops, clinical 
effects at least in the two subgroups without a history of 
symptoms from the lower airways were not expected. Nor 
were heavier symptoms expected in the WS group as the 
inclusion criteria were symptoms from the lower airways 
at least once in the last month and as the group consisted 
of subjects without clear asthma—only one subject medi-
cated more frequently for asthma-like symptoms (salbuta-
mol inhalation).
The decrease in nasal symptoms during welding fume 
exposure was unexpected. To our knowledge this has not 
earlier been described. The reaction may be explained by 
a neurogenic mechanism as during treatment with cam-
phor, eucalyptus or menthol (Burrow et al. 1983). Subjects 
at such exposure feel improved without effects on nasal 
resistance to airflow. In the present study, there was a ten-
dency towards improvement in acoustic rhinometry mainly 
in the WS group. Thus, it may be hypothesized that such 
a reaction could play a role in development of lower air-
ways symptoms as the exposure to the lower airways may 
increase.
In a previous study we found increased symptoms in 
welders during working days. The welders were in this 
study exposed not only to welding fumes, but also to par-
ticles from grinding (Jönsson et  al. 2015). In the present 
study the participants were only exposed to welding fumes. 
This indicates that symptoms are either caused mainly 
by particles from grinding, or that the welding exposure 
in the chamber differed from that in the working places. 
The exposure was well reproduced during all experiments 
(Isaxon et  al. 2013). The  PM2.5 mean mass concentration 
was about 1 mg/m3 during the 5.5 h of exposure. As no par-
ticles above 2.5 µm were found, our results are comparable 
to the level of respirable particles as given in the Swedish 
occupational exposure limit (OEL) for inorganic dust 
(Swedish Work Environment Authority 2015). The expo-
sure level is also in the range of that found in the Swedish 
welding industry (geometric mean: 1.3  mg/m3, minimum 
0.1 mg/m3, maximum 38 mg/m3; Hedmer et  al. 2014). In 
the present chamber study and in the earlier panel study in 
the workplaces, the ozone exposure was low; we therefore 
think that the effects come from the particles. However, 
as mentioned above in the welding industry dust exposure 
is also generated from other sources and thus containing 
particles with somewhat larger diameter than those in the 
welding fume.
The exposure level tested was chosen to secure a man-
ganese (Mn) exposure below the OEL (respirable fraction 
0.1 mg/m3, 8 h time-weighted, Swedish Work Environment 
Authority 2015).
Although iron was the dominant substance during expo-
sure (70%), the level of Mn was just below the Swedish 
OEL (Isaxon et al. 2013). In a recent study of the Swedish 
welding industry, the exposure level of Mn was rather high 
(respirable fraction 0.08, <0.01–2.13  mg/m3, geometric 
mean, min–max) and more than 50% of the Mn measure-
ments exceeded the occupational exposure limit (Hedmer 
et al. 2014). The critical effect of Mn is neurotoxic, but the 
effect on the airways is not as well investigated. Han et al. 
(2005) found that exposure to welding may cause changes 
in serum biomarkers of oxidative stress and an associa-
tion between the serum level of manganese and manga-
nese superoxide dismutase and glutathione peroxidase was 
found. Furthermore, Hałatek et  al. (2005) saw that Club 
cell protein secretion was inhibited in younger welders not 
adapted to the manganese in shipyard welding. Thus man-
ganese in welding fume may influence the airways.
Although no adverse clinical effects were registered in 
the present study, changes of several markers of inflamma-
tion were noticed during and after welding exposure, com-
pared with filtered air. However, conclusions from such 
changes are not straight forward. Inflammation mediators 
may have a diurnal variation (Kendzia et al. 2012; Sennels 
Table 8  LT-B4 (pg/ml, median, min, max) in exhaled breath con-
densate before, at half time and immediately after exposure to weld-
ing and filtered air (FA), respectively, in the total group and in the 
subgroups of welders with symptoms from the lower airways (WS), 
welders without symptoms (WNS) and in healthy non-welders 
(NWNS)
p values for the differences between welding and FA: p = 0.48 (before), p = 0.08 (at half time) and p = 0.02 (after)
LT-B4 in EBC Total group WS WNS NWNS
Welding Before 50.0 (6.0, 504.0) 228.0 (6.0, 504.0) 29.0 (7.0, 447.0) 27.0 (7.0, 337.0)
At half time 38.5 (6.0, 473.0) 309.0 (8.0, 473.0) 32.0 (11.0, 238.0) 20.0 (6.0, 238.0)
After 28.0 (2.0, 431.0) 171.0 (12.0, 431.0) 17.5 (7.0, 328.0) 10.0 (2.0, 52.0)
FA Before 70.0 (2.0, 632.0) 204.0 (8.0, 560.0) 31.0 (6.0, 437.0) 20.0 (2.0, 632.0)
At half time 43.0 (0.0, 792.0) 263.0 (0.0, 510.0) 24.5 (12.0, 792.0) 24.0 (4.0, 738.0)
After 79.5 (5.0, 758.0) 328.0 (6.0, 729.0) 79.0 (6.0, 296.0) 17.0 (5.0, 758.0)
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et al. 2011). In this study, all exposure events followed the 
same time schedule and the results are calculated as the 
differences between exposure to welding fumes and fil-
tered air. Thus, diurnal variations as explanations for the 
changes are not likely. Furthermore, some of the markers 
in the blood may be influenced by the hydration status of 
the participant which may differ between exposure to weld-
ing fumes and filtered air. However, as no changes were 
found in blood haemoglobin, this is not likely to explain the 
differences.
A limitation when many relationships are tested is the 
risk of false-positive findings (mass significances). We 
therefore focus our conclusions on findings where there 
are logical relationships between the changes in biomark-
ers and a reasonable biological hypothesis. However, the 
knowledge concerning the dynamics of inflammatory mark-
ers (especially when studied in different sampling media) 
is yet incomplete (Scarpa et al. 2014). As always, findings 
should thus be reproduced in other studies for confirmation.
Thus, we found an increase in blood neutrophils imme-
diately after exposure to welding, most in the WS group. 
This may indicate an effect of the exposure. An increase in 
neutrophils was also found by Dewald et al. (2015) imme-
diately after manual metal arc welding. The authors inter-
preted this as a sign of a subclinical inflammatory reaction.
The day after exposure the blood neutrophils decreased 
significantly, as did IL-8 in serum. IL-8 is a neutrophil 
attractant, thus an association may be expected. This is in 
contrast to the findings in firefighters after exposure (Gre-
ven et al. 2012), where an increase of both neutrophils and 
IL-8 in serum was noticed 24 h after firefighting. The rea-
son for this discrepancy may be the kind or the intensity 
of exposure. Changes in inflammatory cytokines and leu-
kocytes may occur within hours. Park et  al. (1999) found 
that when subjects having a toluene diisocyanate associ-
ated asthma were challenged with TDI, serum neutrophil 
chemotactic activity significantly increased after 10  min 
of exposure and decreased after 60 min and then remained 
unchanged up to 7 h.
We found an increase in IL-6 in nasal lavage at the end 
of the exposure in both non-symptomatic groups. Similar 
results were shown in healthy volunteers 2 h after exposure 
to particles in various outdoor environments (Janssen et al. 
2015). Furthermore, Stenfors et al. (2004) found a signifi-
cant increase in IL-6 in bronchial lavage after exposure to 
diesel fume in healthy controls, but not in mild asthmat-
ics. As IL-6 may play a role in the resolution process of 
inflammation (Xing et al. 1998; Fernando et al. 2014) these 
findings may indicate that non-symptomatic subjects may 
have a higher capability to stop the inflammatory process. 
A protective role of IL-6 has also been suggested in a study 
of firefighters from the World Trade Centre disaster (Cho 
et  al. 2014) and is indicated also in some animal studies 
(Kopf et al. 1994; Wang et al. 2000; DiCosmo et al. 1994). 
The levels of IL-6 and IL-8 are in the same range as seen 
in an earlier study from our department (Xu et  al. 2013), 
but the significant changes in the present study differ from 
changes found in the former study.
LT-B4 in EBC decreased during the welding exposure 
in the whole group. This mediator has chemo-attractant 
and furthermore activating properties to neutrophils and 
should thus develop parallel to IL-8. IL-8 decreased later, 
but it was measured in serum. Our finding is in contrast to 
that in ozone-sensitive subjects who increased in LT-B4 
after ozone exposure (Alfaro et al. 2007). The most remark-
able result was that the symptomatic welders before expo-
sure had a tenfold higher pre-exposure level of LT-B4 at 
both exposure events than the other two groups. An effect 
on LT-B4 in EBC in welders has earlier been suggested 
(Hoffmeyer et  al. 2012; Mittmann-Frank et  al. 2011), but 
to our knowledge, elevated levels have not been associated 
with symptoms in the welders previously.
Taken together our interpretation of the results is that the 
rapid decrease in LT-B4 in EBC is a true effect of expo-
sure to welding fume nanoparticle aggregates, followed by 
a subsequent decrease in neutrophils and IL-8 in blood. In 
a sensitive subgroup of welders with work-related airway 
symptoms, however, chronic exposure to welding fumes 
may lead to increased EBC LT-B4 levels, reflecting an 
ongoing neutrophilic low-grade inflammation. This sen-
sitive group is also characterized by a tendency towards 
nasal opening during welding exposure, which could be a 
reason for increased sensitivity to welding fumes. Another 
difference between the sensitive group and the asympto-
matic groups is the increase in IL-6 after acute exposure 
in the latter groups, suggesting that the IL-6-response is 
part of a healthy response that leads to the resolution of the 
local inflammation after exposure. While the causal chain 
is still not clear, this study thus finds that those who have 
developed symptoms in the lower airways from long-term 
exposure to welding fumes differ from the other partici-
pants in their expression of inflammatory cytokines. These 
differences in immune responses should be studied fur-
ther to determine the mechanisms through which welding 
fumes can affect health, as should the possibility of using 
of LT-B4 in exhaled air as an early biomarker of airway 
effects in welders.
In conclusion, although no adverse clinical effects could 
be shown at welding fume exposure well below the Swed-
ish exposure limit (OEL 5  mg/m3 8  h TWA respirable 
dust) and other European exposure limits, responses in the 
inflammatory system may indicate a risk for adverse effects 
in the airways at such exposure.
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